Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Equities research analysts at Cormark cut their FY2024 earnings per share (EPS) estimates for Cresco Labs in a report released on Monday, November 11th. Cormark analyst J. Pytlak now forecasts that the company will post earnings of ($0.21) per share for the year, down from their prior forecast of ($0.17). Cormark has a “Hold” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Cormark also issued estimates for Cresco Labs’ FY2025 earnings at $0.03 EPS.
CRLBF has been the subject of a number of other reports. Ventum Cap Mkts upgraded Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Finally, Roth Capital raised Cresco Labs to a “strong-buy” rating in a research report on Sunday, November 10th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $2.50.
Cresco Labs Stock Down 0.7 %
Shares of OTCMKTS:CRLBF opened at $1.39 on Thursday. The company has a fifty day moving average of $1.57 and a 200-day moving average of $1.70. The company has a market capitalization of $678.51 million, a PE ratio of -7.00 and a beta of 1.88. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.30 and a current ratio of 1.97. Cresco Labs has a 52-week low of $1.02 and a 52-week high of $2.65.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Read More
- Five stocks we like better than Cresco Labs
- CD Calculator: Certificate of Deposit Calculator
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What is a Secondary Public Offering? What Investors Need to Know
- Top-Performing Non-Leveraged ETFs This Year
- Why is the Ex-Dividend Date Significant to Investors?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.